Skip to main content

FDA delays approval of Remoxy painkiller


NEW YORK The Food and Drug Administration announced that it needed more clinical studies of the pain pill Remoxy before it would approve it.

The pill, a formulation of oxycodone by King Pharmaceuticals and Pain Therapeutics, is designed in a capsule form that prevents abuse by people trying to get high.

On Wednesday, King Pharmaceuticals’ shares were down by 83 cents, at $9.13, and Pain Therapeutics were down by $1.82, at $5.93.

This ad will auto-close in 10 seconds